[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SEC Filings Digest @USCorpFilings on x 4385 followers
Created: 2025-07-23 12:30:06 UTC
$IRD Joint Ventures:
Opus Genetics, Inc. announced on July 22, 2025, a funding and license agreement allowing for up to $XXX million to develop gene therapies for inherited retinal degeneration associated with the RDH12 gene.
XXX engagements
Related Topics joint ventures $ird